Testing the risk of bias tool showed low reliability between individual reviewers and across consensus assessments of reviewer pairs
- PMID: 22981249
- DOI: 10.1016/j.jclinepi.2012.07.005
Testing the risk of bias tool showed low reliability between individual reviewers and across consensus assessments of reviewer pairs
Abstract
Objectives: To assess the reliability of the Cochrane Risk of Bias (ROB) tool between individual raters and across consensus agreements of pairs of reviewers and examine the impact of study-level factors on reliability.
Study design and setting: Two reviewers assessed risk of bias for 154 randomized controlled trials (RCTs). For 30 RCTs, two reviewers from each of four centers assessed risk of bias and reached consensus. We assessed interrater agreement using kappas and the impact of study-level factors through subgroup analyses.
Results: Reliability between two reviewers was fair for most domains (κ=0.24-0.37), except sequence generation (κ=0.79, substantial). Reliability results across reviewer pairs: sequence generation, moderate (κ=0.60); allocation concealment and "other sources of bias," fair (κ=0.37-0.27); and other domains, slight (κ=0.05-0.09). Reliability was influenced by the nature of the outcome, nature of the intervention, study design, trial hypothesis, and funding source. Variability resulted from different interpretation of the tool rather than different information identified in the study reports.
Conclusion: Low agreement has implications for interpreting systematic reviews. These findings suggest the need for detailed guidance in assessing the risk of bias.
Keywords: Internal validity; Meta-Analysis; Randomized controlled trials; Reliability; Risk of bias; Systematic reviews.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Disagreements in risk of bias assessment for randomized controlled trials in hypertension-related Cochrane reviews.Trials. 2024 Jun 21;25(1):405. doi: 10.1186/s13063-024-08145-2. Trials. 2024. PMID: 38907276 Free PMC article.
-
Validity and Inter-Rater Reliability Testing of Quality Assessment Instruments [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Mar. Report No.: 12-EHC039-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Mar. Report No.: 12-EHC039-EF. PMID: 22536612 Free Books & Documents. Review.
-
Poor reliability between Cochrane reviewers and blinded external reviewers when applying the Cochrane risk of bias tool in physical therapy trials.PLoS One. 2014 May 13;9(5):e96920. doi: 10.1371/journal.pone.0096920. eCollection 2014. PLoS One. 2014. PMID: 24824199 Free PMC article.
-
Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews.BMJ. 2013 Apr 22;346:f1798. doi: 10.1136/bmj.f1798. BMJ. 2013. PMID: 23610376
-
Evaluation of the reliability, usability, and applicability of AMSTAR, AMSTAR 2, and ROBIS: protocol for a descriptive analytic study.Syst Rev. 2018 Jun 13;7(1):85. doi: 10.1186/s13643-018-0746-1. Syst Rev. 2018. PMID: 29898777 Free PMC article. Review.
Cited by
-
Are preoperative serum cancer antigen 125 levels a prognostic factor for outcome in epithelial ovarian cancer? A systematic review.Niger Med J. 2024 May 23;65(2):108-118. doi: 10.60787/nmj-v65i2-418. eCollection 2024 Mar-Apr. Niger Med J. 2024. PMID: 39005560 Free PMC article. Review.
-
Disagreements in risk of bias assessment for randomized controlled trials in hypertension-related Cochrane reviews.Trials. 2024 Jun 21;25(1):405. doi: 10.1186/s13063-024-08145-2. Trials. 2024. PMID: 38907276 Free PMC article.
-
Inter-Rater Agreement in Assessing Risk of Bias in Melanoma Prediction Studies Using the Prediction Model Risk of Bias Assessment Tool (PROBAST): Results from a Controlled Experiment on the Effect of Specific Rater Training.J Clin Med. 2023 Mar 2;12(5):1976. doi: 10.3390/jcm12051976. J Clin Med. 2023. PMID: 36902763 Free PMC article.
-
Automating Quality Assessment of Medical Evidence in Systematic Reviews: Model Development and Validation Study.J Med Internet Res. 2023 Mar 13;25:e35568. doi: 10.2196/35568. J Med Internet Res. 2023. PMID: 36722350 Free PMC article.
-
Extension of the Composite Quality Score (CQS) as an appraisal tool for prospective, controlled clinical therapy trials-A systematic review of meta-epidemiological evidence.PLoS One. 2022 Dec 30;17(12):e0279645. doi: 10.1371/journal.pone.0279645. eCollection 2022. PLoS One. 2022. PMID: 36584067 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
